An introduction to the research
Explore the molecules, mechanisms and methods behind the research. Understand what a finding shows, where its limits lie, and how to follow the evidence.
An educational resource from Revitalise Research Ltd
Three amino-acid residues.
One short peptide sequence. [3]
01 / The foundations
Peptides are molecules made from amino-acid residues connected by peptide bonds. The order of those residues is called the amino-acid sequence. [1]
“Peptide” describes a chemical class. To understand a particular molecule, researchers investigate its structure, the molecules it interacts with and the changes observed under defined experimental conditions.
Some peptides act as signals. By interacting with a receptor, they can connect an event outside a cell to processes inside it. The GLP-1 receptor study below offers a specific example of this type of research. [2]
02 / Research in context
Each example pairs a scientific finding with the setting in which it was established.
Structural study · 2017
Using cryo-electron microscopy, Zhang and colleagues examined a complex comprising the GLP-1 peptide, its activated receptor and a G protein. The work revealed details of the molecular arrangement involved in signalling. [2]
A structure helps explain a molecular interaction. It does not establish the effects of every peptide or replace studies of outcomes in people.
Cell-culture study · 1988
GHK contains glycine, histidine and lysine and can bind copper(II). Maquart and colleagues reported increased collagen synthesis when they studied GHK-Cu in fibroblast cultures. [3]
The finding applies to the experimental cell cultures. It does not, by itself, demonstrate clinical benefit or safety in people.
Biochemical reference
Nicotinamide adenine dinucleotide participates in oxidation–reduction reactions. Its oxidised form, NAD+, is involved in the biochemical transfer of electrons from one reaction to another. [4]
A molecule’s role in normal biology is a starting point for research. It does not establish the effects of administering it as a product.
The illustrations introduce each topic; they are not molecular structures or experimental data.
03 / Understanding evidence
Choose a research setting to see the questions it can help answer.
Studies using purified molecules or cultured cells can investigate interactions and measurable responses. The GLP-1 structure and GHK-Cu cell-culture experiments are examples. [2] [3]
Keep in view: a laboratory model captures only part of a living organism.
Preclinical research can investigate biological effects and safety questions in a living system. The species, experimental design and measured outcomes define the context of the findings. [5]
Keep in view: findings in an animal model do not establish the same result in people.
Clinical trials investigate interventions in human participants. Their design, comparison groups, duration and outcome measures influence how the results should be interpreted. Possible benefits and adverse effects both matter. [5]
Keep in view: one study’s findings may not apply to every population or use.
A useful question for every paper:
Does the conclusion match the people, model and outcome that were actually studied?
04 / Laboratory analysis
Read a laboratory result alongside its method, units and the question the test was designed to answer.
What is the compound?
Identification testing asks whether the analytical evidence matches the intended substance. A single chromatographic retention time is not specific confirmation of identity. [6]
What else is detected?
Impurity analysis examines other components detected by the method. A reported percentage must be interpreted in the context of that method and its limits. [6]
How much is present?
An assay measures compound content. Mass concentration expresses mass per volume, such as mg/mL. It differs from both total container content and a purity percentage. [6] [7]
Methods, explained
Different techniques provide complementary information.
Chromatography separates components through their different interactions with a stationary phase and a moving phase. HPLC is one form of liquid chromatography. [8] [6]
Mass analysis examines ions using their mass-to-charge characteristics. Combined with suitable methods, it can provide additional evidence when characterising a compound. [9] [6]
Read each stated test separately. Check which sample was analysed, the method, the result and its units. Chemical characterisation and microbiological assessment answer different questions. [6]
Keep chemistry and clinical evidence separate. Analytical results describe measured sample properties. They do not, on their own, establish safety or effectiveness for a use in people. [5] [6]
Follow the evidence
Original studies and authoritative references used on this page. Source links open in a new tab.
International Union of Pure and Applied Chemistry. Definition P04479.
Zhang Y et al. Nature. 2017;546:248–253. DOI: 10.1038/nature22394.
Maquart FX et al. FEBS Letters. 1988;238:343–346. PMID: 3169264.
EMBL-EBI. Chemical definition and biological-role classification.
U.S. Food and Drug Administration. Human studies and study design.
FDA / ICH. Chemical drug substances and products. 2000. Used here to explain analytical concepts.
Definition M03713. Mass per volume.
Definition C01075. Separation using stationary and mobile phases.
Definition M03710. Mass-to-charge analysis.
About this resource
Published by Revitalise Research Ltd as an introduction to the scientific literature. The cited studies were carried out by their named authors and institutions; citations do not imply affiliation or endorsement.
This page provides general scientific information, not individual treatment or dosing advice. It is an introductory selection of references, rather than a comprehensive review.
Last reviewed: